NCT00215852 - A Randomized, Dose-ranging Study of Alferon LDO in Asymptomatic HIV+ Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

April 30, 2009

Study Completion Date

April 30, 2009

Conditions

HIV Infections

Interventions

DRUG

Alferon LDO

500 IU, taken orally each evening, for 10 consecutive days while holding in the mouth for at least 2 minutes prior to swallowing, for 10 daysday 5 of each 28 day cycle.

Trial Locations (2)

19102

Drexel University School of Medicine, Philadelphia

19107

Philadelphia FIGHTS, Philadelphia